본문 바로가기
KERD
논문KCI 등재

Tardive Dyskinesia Associated with Bupropion

Mehmet Akif Camkurt|Taha Can Tuman|Uğur Çakır|Osman Yı ıd ldı ır rı ı m
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2017.05|Clinical Psychopharmacology and Neuroscience|제15권 제2호|pp. 194-196|DOI https://doi.org/10.9758/cpn.2017.15.2.194

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

Depression.BupropionMovement disorders

초록

Present report describes a 46 year old male patient with a diagnosis of major depression who developed tardive dyskinesia during bupropion therapy. Our patient had no history of neuroleptic use and his laboratory and neurologic examinations were normal. He had no family history of neurologic diseases. Although bupropion induced dyskinesia has been previously reported in the literature, it is rare and our case is the first case regarding tardive dyskinesia.

Abstract

Present report describes a 46 year old male patient with a diagnosis of major depression who developed tardive dyskinesia during bupropion therapy. Our patient had no history of neuroleptic use and his laboratory and neurologic examinations were normal. He had no family history of neurologic diseases. Although bupropion induced dyskinesia has been previously reported in the literature, it is rare and our case is the first case regarding tardive dyskinesia.

참고문헌 (19)

  1. Benowitz NL, "Pharmacology of nicotine: addiction, smokinginduced disease, and therapeutics", Annu Rev Pharmacol Toxicol, 49, pp.57~71 (2009)
  2. Richmond R, "Review of bupropion for smoking cessation", Drug Alcohol Rev, 22, pp.203~220 (2003)
  3. Glynn DA, "Update on smoking cessation therapies", Adv Ther, 26, pp.369~382 (2009)
  4. Dwoskin LP, "Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent", CNS Drug Rev, 12, pp.178~207 (2006)
  5. Aggarwal A, "Bupropion-induced mania and hypomania: a report of two cases", J Neuropsychiatry Clin Neurosci, 23, pp.E51~E52 (2011)
  6. Golden RN, "Psychoses associated with bupropion treatment", Am J Psychiatry, 142, pp.1459~1462 (1985)
  7. American Psychiatric Association, "Desk reference to the diagnostic criteria from DSM-5" (2013), American Psychiatric Association Publishing
  8. Kenney C, "Metoclopramide, an increasingly recognized cause of tardive dyskinesia", J Clin Pharmacol, 48, pp.379~384 (2008)
  9. Naranjo CA, "A method for estimating the probability of adverse drug reactions", Clin Pharmacol Ther, 30, pp.239~245 (1981)
  10. Gardos G, "Reversible dyskinesia during bupropion therapy", J Clin Psychiatry, 58, pp.218~ (1997)
  11. Kohen I, "Mirtazapine in bupropion-induced dyskinesias : a case report", Mov Disord, 21, pp.584~585 (2006)
  12. Ferentinos P, "Mixed-type(limb-truncal and orofacial)bupropion-associated dyskinesia", J Clin Psychopharmacol, 30, pp.644~646 (2010)
  13. Damier P, "Drug-induced dyskinesias", Curr Opin Neurol, 22, pp.394~399 (2009)
  14. Na-Ri Kang, "Tardive Dyskinesia: Treatment with Aripiprazole", Clinical Psychopharmacology and Neuroscience, 9(1), pp.1~8 (2011), 대한정신약물학회
  15. Egan MF, "Treatment of tardive dyskinesia", Schizophr Bull, 23, pp.583~609 (1997)
  16. Sachdev PS, "The current status of tardive dyskinesia", Aust N Z J Psychiatry, 34, pp.355~369 (2000)
  17. Heinrich TW, "A case report of methylphenidate-induced dyskinesia", Prim Care Companion J Clin Psychiatry, 4, pp.158~159 (2002)
  18. Luborzewski A, "Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder", J Neuropsychiatry Clin Neurosci, 18, pp.248~249 (2006)
  19. Jiménez-Jiménez FJ, "Druginduced movement disorders", Drug Saf, 16, pp.180~204 (1997)

관련 논문AI추천

Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic DepressionChien-Han Lai, Yi-Cheng Hou대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2014 · 제12권 제2호A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naïve Patient with Two Years of Follow UpRakesh Goyal, Salam Hemabati Devi대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2014 · 제12권 제1호Tardive Dystonia Related with Aripiprazole김민섭, 김성환, 이경욱, 이승엽대한신경정신의학회 · PSYCHIATRY INVESTIGATION2017 · 제14권 제3호Tardive Dyskinesia: Treatment with AripiprazoleMoon Doo Kim, Na-Ri Kang대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2011 · 제9권 제1호Resolution of Tardive Dyskinesia Following a Switch from Long-Acting Injectable Risperidone to Aripiprazole김성완, 김재민, 신일선, 양수진, 윤진상, Sam-Yeon Lee대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2008 · 제6권 제2호Effect of Varenicline on Tardive Dyskinesia: A Pilot StudyAlisa R. Gutman, E. Cabrina Campbell, John Northrop, Rosalind M. Berkowitz, Shirley H. Leong, Stanley N. Caroff대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제2호

이 간행물의 다른 논문 (15건)

Role of Sleep Disturbance in the Trajectory of Alzheimer’s DiseaseChang-Uk Lee, Dong Woo Kang, Hyun Kook Limpp. 89-99Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic ImplicationsAther Muneerpp. 100-114In Silico Model-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia PathophysiologyRimjhim Agrawal, Ganesan Venkatasubramanian, Sunil Vasu Kalmadypp. 115-125Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled TrialYoung Joon Hong, Kyung-Yeol Bae, Jin Sang Yoon, Sung-Wan Kim, Young Keun Ahn, Il-Seon Shin, Jae-Min Kim, Myung Ho Jeong, Hee-Ju Kangpp. 126-131Assessment of the Latent Adverse Events of Antipsychotic Treatment Using a Subjective Questionnaire in Japanese Patients with SchizophreniaNakao Iwata, Masakazu Hatano, Shigeki Yamada, Ippei Takeuchi, Manako Hanya, Hiroyuki Kamei, Junji Uno, Kiyoshi Fujita, Azusa Katopp. 132-137
원문 보기